Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Michael

Showing results (41-50 of 1,129) with videos related to

Pageof 113
Sort By:
Drugs|April 21, 2011
Safety of long-term bisphosphonate therapy for the management of osteoporosisE Michael Lewiecki
Current Medical Research and Opinion|June 15, 2011
Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?E Michael Lewiecki
Current Osteoporosis Reports|April 29, 2010
Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|August 30, 2008
Vertebroplasty and kyphoplasty updateE Michael Lewiecki
Women'S Health (London, England)|March 12, 2009
Denosumab for the treatment of postmenopausal osteoporosisE Michael Lewiecki
Women'S Health (London, England)|October 7, 2009
Update on osteoporosisE Michael Lewiecki
Women'S Health (London, England)|October 7, 2009
Denosumab: a promising drug for the prevention and treatment of osteoporosisE Michael Lewiecki
Nature Reviews. Endocrinology|February 23, 2010
Bone: Using FRAX wisely: lessons from Switzerland and beyondE Michael Lewiecki
Child Development|December 19, 2002
How economists think about family resources and child developmentE Michael Foster
Nursing Management|May 15, 2002
Stay in-the-know regarding informed consentJanet E Michael
Pageof 113

Showing results (41-50 of 1,129) with videos related to

Sort By:
Pageof 113
Drugs|April 21, 2011
Safety of long-term bisphosphonate therapy for the management of osteoporosisE Michael Lewiecki
Current Medical Research and Opinion|June 15, 2011
Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?E Michael Lewiecki
Current Osteoporosis Reports|April 29, 2010
Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosisE Michael Lewiecki
Current Osteoporosis Reports|August 30, 2008
Vertebroplasty and kyphoplasty updateE Michael Lewiecki
Women'S Health (London, England)|March 12, 2009
Denosumab for the treatment of postmenopausal osteoporosisE Michael Lewiecki
Women'S Health (London, England)|October 7, 2009
Update on osteoporosisE Michael Lewiecki
Women'S Health (London, England)|October 7, 2009
Denosumab: a promising drug for the prevention and treatment of osteoporosisE Michael Lewiecki
Nature Reviews. Endocrinology|February 23, 2010
Bone: Using FRAX wisely: lessons from Switzerland and beyondE Michael Lewiecki
Child Development|December 19, 2002
How economists think about family resources and child developmentE Michael Foster
Nursing Management|May 15, 2002
Stay in-the-know regarding informed consentJanet E Michael
Pageof 113